Research in the Ackerman group is predominantly focused on the application of molecular engineering tools and quantitative analysis to the development of immunotherapeutics and vaccines.

Protective Antibodies

Developing tools to parse the humoral immune response to vaccination and infection. Developing a quantitative understanding of antibody functions.

Protein engineering for vaccine design

Developing platforms for combinatorial display and in vitro evolution of candidate vaccine immunogens.